Randi Hagerman

Distinguished Professor, Department of Pediatrics · University of California Davis Health

Credentials: · · · · ·

History

Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
Case report · Neurology · 2001 · First of 9 authors · Corresponding · 742 citations
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome
The American Journal of Human Genetics · 2000 · 664 citations
Fragile X syndrome
Review · Nature Reviews Disease Primers · 2017 · First of 11 authors · 592 citations

Genotype-Phenotype Relationships in Fragile X Families
National Institute of Child Health and Human Development · R01
Contact PI · $14.5M · University of California at Davis
1998–2028
Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS)
National Institute of Neurological Disorders and Stroke · U01
PI · $11.5M · Rush University Medical Center
2016–2023
Cell and Gene Therapy for Neurodevelopmental Disorders Conference
National Institute of Neurological Disorders and Stroke · R13
PI · $10K · University of California at Davis
2021–2022
MIND Institute Intellectual and Developmental Disabilities Research Center
National Institute of Child Health and Human Development · U54
Project lead · $2.1M · University of California at Davis
2013–2020

A Trial of Metformin in Individuals With Fragile X Syndrome
Principal investigator · Completed · Phase 2, Phase 3
University of California, Davis
2018–2024
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
Principal investigator · Completed · Phase 4
University of California, Davis
2016–2018
Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
Principal investigator · Completed · Phase 2
Randi J. Hagerman, MD
2015–2017
A Trial of Sertraline in Young Children With Autism Spectrum Disorder
Principal investigator · Completed · Phase 2
Randi J. Hagerman, MD
2015–2018